Ticker Details
Allogene Therapeutics, Inc.
IPO Date:	October 8, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$722.08M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.43 | 3.46%
Avg Daily Range (30 D):	$0.07 | 3.41%
Avg Daily Range (90 D):	$0.07 | 3.23%

Institutional Daily Volume
Avg Daily Volume:	2.06M
Avg Daily Volume (30 D):	5.34M
Avg Daily Volume (90 D):	7.98M

Trade Size
Avg Trade Size (Sh.):	174
Avg Trade Size (Sh.) (30 D):	279
Avg Trade Size (Sh.) (90 D):	308

Institutional Trades
Total Institutional Trades:	3,073
Avg Institutional Trade:	$1.85M
Avg Institutional Trade (30 D):	$.91M
Avg Institutional Trade (90 D):	$1.8M
Avg Institutional Trade Volume:	.21M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.39M
Avg Closing Trade (30 D):	$.91M
Avg Closing Trade (90 D):	$1.85M
Avg Closing Volume:	284.81K

News

Apr 15, 2026 @ 1:50 AM Allogene Therapeutics Announces Pricing of Public ... Source: Na

Dec 16, 2025 @ 6:09 PM Allogene Arbitration Victory Pressures Cellectis S... Source: Vandana Singh

Dec 15, 2025 @ 10:39 PM Allogene Therapeutics Reports Favorable Result for... Source: Allogene Therapeutics

Nov 27, 2025 @ 4:00 PM U.S. CAR T-Cell Therapies Market Grows at 30.4% CA... Source: Towards Healthcare

Jul 23, 2025 @ 1:26 PM High‑Growth Oncology Market Projected For U... Source: Prnewswire

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.13	$-.18	$-.17
Diluted EPS	$-.13	$-.18	$-.17
Revenue	$4.64M	$M	$M
Gross Profit
Net Income / Loss	$-42.68M	$-42.61M	$-38.81M
Operating Income / Loss	$-46.92M	$-46.09M	$-42.4M
Cost of Revenue
Net Cash Flow	$8.32M	$-21.38M	$13.87M
PE Ratio